Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Non-Current Debt (2023 - 2025)

Historic Non-Current Debt for Utah Medical Products (UTMD) over the last 8 years, with Q3 2025 value amounting to $241000.0.

  • Utah Medical Products' Non-Current Debt changed N/A to $241000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $241000.0, marking a year-over-year change of. This contributed to the annual value of $282000.0 for FY2024, which is 440.68% down from last year.
  • As of Q3 2025, Utah Medical Products' Non-Current Debt stood at $241000.0.
  • In the past 5 years, Utah Medical Products' Non-Current Debt ranged from a high of $295000.0 in Q4 2023 and a low of $241000.0 during Q3 2025
  • Over the past 3 years, Utah Medical Products' median Non-Current Debt value was $275500.0 (recorded in 2024), while the average stood at $271750.0.
  • Data for Utah Medical Products' Non-Current Debt shows a peak YoY increase of 440.68% (in 2024) and a maximum YoY decrease of 440.68% (in 2024) over the last 5 years.
  • Over the past 3 years, Utah Medical Products' Non-Current Debt (Quarter) stood at $295000.0 in 2023, then fell by 4.41% to $282000.0 in 2024, then decreased by 14.54% to $241000.0 in 2025.
  • Its last three reported values are $241000.0 in Q3 2025, $269000.0 for Q1 2025, and $282000.0 during Q4 2024.